These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19715842)

  • 21. Induction immunosuppressive therapy in renal transplantation: does basiliximab make the difference?
    Jorge S; Guerra J; Silva S; Santana A; Mil-Homens C; Prata MM
    Transplant Proc; 2008 Apr; 40(3):693-6. PubMed ID: 18454989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids.
    Offner G; Toenshoff B; Höcker B; Krauss M; Bulla M; Cochat P; Fehrenbach H; Fischer W; Foulard M; Hoppe B; Hoyer PF; Jungraithmayr TC; Klaus G; Latta K; Leichter H; Mihatsch MJ; Misselwitz J; Montoya C; Müller-Wiefel DE; Neuhaus TJ; Pape L; Querfeld U; Plank C; Schwarke D; Wygoda S; Zimmerhackl LB
    Transplantation; 2008 Nov; 86(9):1241-8. PubMed ID: 19005406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of basiliximab on renal allograft rejection within 1 year after transplantation.
    Lee BM; Oh CK; Jin SH; Kim JH; Kim SJ; Kim H; Shin GT
    Transplant Proc; 2006 Sep; 38(7):2025-8. PubMed ID: 16979988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal retransplantation: a retrospective monocentric study.
    Ott U; Busch M; Steiner T; Schubert J; Wolf G
    Transplant Proc; 2008 Jun; 40(5):1345-8. PubMed ID: 18589102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction therapy in simultaneous pancreas-kidney transplantation: thymoglobulin versus basiliximab.
    Fernández-Burgos I; Montiel Casado MC; Pérez-Daga JA; Aranda-Narváez JM; Sánchez-Pérez B; León-Díaz FJ; Cabello-Díaz M; Rodríguez-Burgos D; Hernández-Marrero D; Santoyo-Santoyo J
    Transplant Proc; 2015; 47(1):120-2. PubMed ID: 25645787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early outcomes of thymoglobulin and basiliximab induction in kidney transplantation: application of statistical approaches to reduce bias in observational comparisons.
    Willoughby LM; Schnitzler MA; Brennan DC; Pinsky BW; Dzebisashvili N; Buchanan PM; Neri L; Rocca-Rey LA; Abbott KC; Lentine KL
    Transplantation; 2009 May; 87(10):1520-9. PubMed ID: 19461489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function.
    Andrés A; Marcén R; Valdés F; Plumed JS; Solà R; Errasti P; Lauzurica R; Pallardó L; Bustamante J; Amenábar JJ; Plaza JJ; Gómez E; Grinyó JM; Rengel M; Puig JM; Sanz A; Asensio C; Andrés I;
    Clin Transplant; 2009; 23(1):23-32. PubMed ID: 18798851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose Thymoglobulin vs Basiliximab Induction Therapy in Low-Risk Living Related Kidney Transplant Recipients: A Prospective Randomized Trial.
    Martinez-Mier G; Moreno-Ley PI; Budar-Fernández LF; Méndez-López MT; Allende-Castellanos CA; Jiménez-López LA; Barrera-Amoros DA; Aguilar-Sandoval E; De la Paz-Román M; Soto-Miranda E; Rivera-Sanchez Y; Martínez-Maldonado M
    Transplant Proc; 2021 Apr; 53(3):1005-1009. PubMed ID: 32178925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction.
    Delgado DH; Miriuka SG; Cusimano RJ; Feindel C; Rao V; Ross HJ
    J Heart Lung Transplant; 2005 Feb; 24(2):166-9. PubMed ID: 15701432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy.
    Mattei MF; Redonnet M; Gandjbakhch I; Bandini AM; Billes A; Epailly E; Guillemain R; Lelong B; Pol A; Treilhaud M; Vermes E; Dorent R; Lemay D; Blanc AS; Boissonnat P
    J Heart Lung Transplant; 2007 Jul; 26(7):693-9. PubMed ID: 17613399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The renal-sparing efficacy of basiliximab in adult living donor liver transplantation.
    Lin CC; Chuang FR; Lee CH; Wang CC; Chen YS; Liu YW; Jawan B; Chen CL
    Liver Transpl; 2005 Oct; 11(10):1258-64. PubMed ID: 16184544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of anti-T-cell therapy in the immunogenicity of seasonal influenza vaccine in kidney transplant recipients.
    Orcurto A; Pascual M; Hoschler K; Aubert V; Meylan P; Manuel O
    Transplantation; 2012 Sep; 94(6):630-6. PubMed ID: 22895612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective immunoprophylaxis with basiliximab plus triple therapy in renal transplantation: five-year single-center experience.
    Kandus A; Grego K; Arnol M; Kovac D; Lindic J; Buturović J; Ponikvar R; Bren AF
    Transplant Proc; 2006 Nov; 38(9):2853-5. PubMed ID: 17112847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring of circulating antibodies in a renal transplantation population: preliminary results.
    Rodríguez Ferrero ML; Arroyo D; Panizo N; Vicario JL; Balas A; Anaya F
    Transplant Proc; 2012 Nov; 44(9):2548-50. PubMed ID: 23146450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-Dose Thymoglobulin versus Basiliximab Induction Therapy in Low-Risk Living Related Kidney Transplant Recipients: Three-Year Follow-Up Study.
    Martinez-Mier G; Moreno-Ley PI; Budar-Fernández LF; Méndez-López MT; Allende-Castellanos CA; Jiménez-López LA; Barrera-Amoros DA; Reyes-Ruiz JM
    Arch Med Res; 2024 Sep; 55(6):103047. PubMed ID: 39079480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of Thymoglobulin Induction Therapy in Kidney Transplant From Deceased Donor With Mild to Moderate Acute Kidney Injury.
    Lee CH; Gwon JG; Jung CW
    Transplant Proc; 2019 Oct; 51(8):2611-2614. PubMed ID: 31474447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basiliximab (Simulect) in acute tubular necrosis high-risk kidney transplantation.
    Rivera CF; Hernández AA; Verdejo PV; García JO; Rego SC; Cañedo FV
    Transplant Proc; 2005 Nov; 37(9):3733-5. PubMed ID: 16386521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.
    Montini G; Murer L; Ghio L; Pietrobon B; Ginevri F; Ferraresso M; Cardillo M; Scalamogna M; Perfumo F; Edefonti A; Zanon GF; Zacchello G
    Transpl Int; 2005 Jan; 18(1):36-42. PubMed ID: 15612981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.